Parse Biosciences

Parse Biosciences is building scalable single-cell sequencing platforms for researchers. One of the latest advances in genomics is single-cell technologies, however, most use microfluidic instruments that limit cell sizes and number and produce high multiplets. Parse has developed the Parse Evercode single-cell technology that enables all scales of experiments without the limitation of today’s microfluidics. Evercode offers single-cell profiling from 10,000 to 1 million cells in a single experiment, flexibility with sample scheduling and unmatched sensitivity. Evercode combinatorial barcoding technology eliminates the need for expensive hardware, making single cell insights accessible to biological researchers in any lab.

Jobs: